Skip to main content

Zoetis Value Stock - Dividend - Research Selection

Zoetis

ISIN: US98978V1035, WKN: A1KBYX

Market price date: 01.06.2021
Market price: 174,19 USD




Zoetis Fundamental data and company key figures of the share

Annual reports in USD
Key figures 24-02-2021
Cash flow
Net operating cash flow 2.126.000.000
Capital Expenditures -453.000.000
Free cash flow 1.672.999.936
Balance sheet
Total Equity 3.769.000.000
Liabilities & Shareholders equity 13.609.000.000
Income statement
Net income 1.638.000.000
Eps (diluted) 3,446
Diluted shares outstanding 475.318.000
Net sales/revenue 6.675.000.000

Fundamental ratios calculated on: 01-06-2021

Ratios
Key figures 01-06-2021
Cash flow
P/C 38,94
   
P/FC 49,49
Balance sheet
ROI12,04
ROE27,70
Income statement
P/E50,55
Div. Yield0,49%
P/B21,97
P/S12,40


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolZTS
Market Capitalization82.795.642.880,00 USD
Country
IndicesS&P 500
Sectors
Raw Data SourceUS GAAP in Millionen USD
Stock Split
Internetwww.zoetis.com


Description of the company

Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. It operates through two segments: the United States and International. Within each of these segments, it offers a diversified product portfolio for both livestock and companion animal customers. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties. It also offers other product categories, such as nutritionals and agribusiness.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.zoetis.com